Literature DB >> 4004170

The initial diagnosis of multiple sclerosis: clinical impact of magnetic resonance imaging.

S S Gebarski, T O Gabrielsen, S Gilman, J E Knake, J T Latack, A M Aisen.   

Abstract

Thirty patients in whom the initial diagnosis of multiple sclerosis was clinically entertained underwent cranial magnetic resonance imaging (MRI) in close temporal relationship to cranial x-ray computed tomography (CT), electrodiagnostic studies (visual evoked responses, brainstem auditory evoked responses, and somatosensory evoked responses), and cerebrospinal fluid analyses (oligoclonal bands, myelin basic protein, and IgG/albumin ratio). In 26 of the 30 patients, MRI demonstrated lesions consistent with multiple sclerosis that corresponded, at least in part, with the clinically expected neuroanatomical lesion distribution. Two of the 4 patients with normal MRI had normal electrodiagnostic studies and cerebrospinal fluid analyses, and the other 2 had a single abnormal or equivocal electrodiagnostic study. All 26 patients with abnormal MRI had at least one other abnormal laboratory test. CT revealed only the largest lesions, and in the patients with abnormal CT, MRI demonstrated even more lesions. MRI, in this limited series, proved to be a strong tool in the initial diagnosis of multiple sclerosis; it may prove to be the single best test, with a sensitivity exceeding that of electrodiagnostic studies and cerebrospinal fluid analysis.

Entities:  

Mesh:

Year:  1985        PMID: 4004170     DOI: 10.1002/ana.410170509

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  15 in total

1.  One-year MR imaging follow-up of patients with multiple sclerosis under cortisone therapy.

Authors:  D Uhlenbrock; E Herbe; D Seidel; W Gehlen
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

2.  A prospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis.

Authors:  E Paolino; E Fainardi; P Ruppi; M R Tola; V Govoni; I Casetta; V C Monetti; E Granieri; M Carreras
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

3.  Evaluation by MRI of paraparesis and tetraparesis of undiagnosed aetiology.

Authors:  E B Ringelstein; D Krieger; B Hünermann
Journal:  J Neurol       Date:  1987-08       Impact factor: 4.849

4.  Aphemia as a first symptom of multiple sclerosis.

Authors:  D Herderscheê; J Stam; M M Derix
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-04       Impact factor: 10.154

5.  Correlation between multimodal evoked potentials and magnetic resonance imaging in multiple sclerosis.

Authors:  G Comi; V Martinelli; S Medaglini; T Locatelli; M Filippi; N Canal; F Triulzi; A Del Maschio
Journal:  J Neurol       Date:  1989-01       Impact factor: 4.849

6.  Magnetic resonance imaging of spinal cord lesions in multiple sclerosis.

Authors:  L S Honig; W A Sheremata
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-04       Impact factor: 10.154

7.  Magnetic resonance imaging of monocytes labeled with ultrasmall superparamagnetic particles of iron oxide using magnetoelectroporation in an animal model of multiple sclerosis.

Authors:  Raoul D Oude Engberink; Susanne M A van der Pol; Pjotr Walczak; Annette van der Toorn; Max A Viergever; Christine D Dijkstra; Jeff W M Bulte; Helga E de Vries; Erwin L A Blezer
Journal:  Mol Imaging       Date:  2010-10       Impact factor: 4.488

8.  Multiple sclerosis associated with trismus.

Authors:  D F D'Costa; A K Vania; P A Millac
Journal:  Postgrad Med J       Date:  1990-10       Impact factor: 2.401

9.  Paroxysmal atrial fibrillation associated with an attack of multiple sclerosis.

Authors:  Y Chagnac; G Martinovits; R Tadmor; Y Goldhammer
Journal:  Postgrad Med J       Date:  1986-05       Impact factor: 2.401

10.  Familial multiple sclerosis: MRI findings in clinically affected and unaffected siblings.

Authors:  P J Tienari; O Salonen; J Wikström; L Valanne; J Palo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.